11 completed, 4 terminated, 1 active not recruiting, 1 not yet recruiting. 20 Phase 3, 5 Phase 2.
Follow Lorazepam: new trials by email Literature Review of Lorazepam trials Research Report on Lorazepam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia Methoxyflurane - Penthrox, Control, Percocet Pill - Benign Prostate Hypertrophy(BPH) | Phase 3 | Not yet recruiting | University of Manitoba | 48 | 2025-08-01 | 2025-06-12 |
| Acute Agitation in Emergency Psychiatry Sublingual Dexmedetomidine, Buccal midazolam, Oral lorazepam - Agitation | Phase 2 / Phase 3 | Recruiting | Lone Baandrup | 132 | 2024-12-30 | 2025-01-01 |
| Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult Dexmedetomidine, Lorazepam, Haloperidol - Altered Mental Status | Phase 3 | Unknown | State University of New York - Upstate Medical University | 60 | 2024-06-01 | 2024-04-22 |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care Haloperidol, Lorazepam, Placebo - Delirium, Locally Advanced Malignant Neoplasm | Phase 2 / Phase 3 | Active not recruiting | M.D. Anderson Cancer Center | 110 | 2019-07-17 | 2026-06-15 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan Lorazepam - Status Epilepticus | Phase 3 | Completed | Pfizer | 26 | 2014-11-01 | 2019-02-18 |
| Clobazam Use in Epilepsia Partialis Continua - Pilot Study Clobazam, Clonazepam, Lorazepam - Epilepsia Partialis Continua, Kojewnikov's Epilepsy | Phase 3 | Terminated | The Cooper Health System | 7 | 2014-07-01 | 2018-05-09 |
| Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly etifoxine, lorazepam, Placebo - Healthy Volunteers | Phase 3 | Completed | Biocodex | 31 | 2013-12-01 | 2016-07-27 |
| Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus Clonazepam, Fosphenytoin, Placebo - Status Epilepticus, Epilepsy | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 434 | 2013-06-26 | 2018-10-11 |
| Promethazine vs. Lorazepam for Treatment of Vertigo Promethazine, Lorazepam - Peripheral Vertigo. | Phase 3 | Completed | Shahid Beheshti University of Medical Sciences | 210 | 2013-04-01 | 2013-06-14 |
| Sedative Premedication: Efficacy On Patient Experience Lorazepam, no premedication, Placebo (microcrystalline celluloses) - Perioperative Anxiety | Phase 3 | Completed | Assistance Publique Hopitaux De Marseille | 1200 | 2012-11-01 | 2015-04-21 |
| Stanford Accelerated Recovery Trial (START) Gabapentin, Lorazepam (active control), Placebo (inactive) - Pain, Breast Cancer | Phase 3 | Terminated | Stanford University | 422 | 2010-05-01 | 2022-05-05 |
| Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Intramuscular route of active treatment, Intravenous route of active treatment - Status Epilepticus | Phase 3 | Completed | Robert Silbergleit | 1023 | 2009-06-01 | 2016-06-17 |
| Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children Lorazepam - Status Epilepticus, Seizures | Phase 3 | Completed | All India Institute of Medical Sciences | 140 | 2008-05-01 | 2009-05-05 |
| Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) lorazepam or diazepam - Status Epilepticus | Phase 2 / Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 259 | 2008-02-01 | 2012-12-18 |
| Seizure Therapy With Intravenous Levetiracetam and Lorazepam Levetiracetam 1 g IV + Lorazepam 2 mg IV, Placebo + Lorazepam 3 mg IV - Seizures | Phase 2 / Phase 3 | Withdrawn | Massachusetts General Hospital | 2008-01-01 | 2012-11-01 | |
| Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia IM olanzapine, IM haloperidol plus lorazepam - Schizophrenia, Schizoaffective Disorder | Phase 3 | Completed | National Taiwan University Hospital | 67 | 2006-07-01 | 2014-09-15 |
| Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children. Lorazepam - Status Epilepticus, Convulsions | Phase 3 | Terminated | Kamuzu University of Health Sciences | 800 | 2006-06-01 | 2012-07-10 |
| Lorazepam Sedation for Critically Ill Children Lorazepam, Midazolam, Lorazepam CI - Critical Illness | Phase 2 / Phase 3 | Completed | The Emmes Company, LLC | 179 | 2004-09-01 | 2023-03-20 |
| Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus diazepam, lorazepam - Status Epilepticus | Phase 3 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 210 | 1995-11-01 | 2005-06-24 |
Status Epilepticus (7) · Seizures (6) · Epilepsy (3) · Psychomotor Agitation (2) · Schizophrenia (2) · Anxiety Disorders (1) · Breast Neoplasms (1) · Critical Illness (1) · Delirium (1) · Dementia (1) · Depression (1) · Epilepsia Partialis Continua (1) · Epilepsy, Partial, Motor (1) · Lung Neoplasms (1) · Mental Disorders (1)
All India Institute of Medical Sciences (1) · Assistance Publique - Hôpitaux de Paris (1) · Assistance Publique Hopitaux De Marseille (1) · Biocodex (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Hannover Medical School (1) · Kamuzu University of Health Sciences (1) · Lone Baandrup (1) · M.D. Anderson Cancer Center (1) · Massachusetts General Hospital (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · National Taiwan University Hospital (1) · Pfizer (1) · Robert Silbergleit (1) · Shahid Beheshti University of Medical Sciences (1)
United States (6) · France (3) · Canada (2) · Brazil (1) · Denmark (1) · Germany (1) · India (1) · Iran (1) · Japan (1) · Malawi (1) · Taiwan (1)
Daniel H Lowenstein, MD (1) · Daniel Lowenstein (1) · David Hui (1) · Elizabeth Molyneux (1) · Helge Frieling, Prof., MD (1) · Ian R Carroll (1) · James Chamberlain, MD (1) · Jeffrey L Blumer, MD, PhD (1) · Joshua N. Goldstein, MD, PhD (1) · Lone Baandrup, MD, DMSc (1) · Melissa Carran, MD (1)
PMID 21275979, PMID 21967361, PMID 22144928, PMID 22335736, PMID 22506949, PMID 22950484, PMID 24001080, PMID 24756515, PMID 25734733, PMID 25791540, PMID 27993298, PMID 28781452, PMID 29238824, PMID 30135030, PMID 30821824, PMID 32029262, PMID 33692709, PMID 33728561, PMID 34238838, PMID 34546899, PMID 34820831, PMID 35971024, PMID 35987977, PMID 36448276, PMID 40742738
2017 (1), 2023 (1), U01NS056975 (1)